The Technical Analyst
Health Catalyst Inc [HCAT]
Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
Health Catalyst Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
-2.02% $5.58
America/New_York / 19 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 326.78 mill |
| EPS: | -2.09 |
| P/E: | -2.67 |
| Earnings Date: | May 07, 2024 |
| SharesOutstanding: | 58.56 mill |
| Avg Daily Volume: | 0.613 mill |
| RATING 2024-04-19 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -2.67 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -2.67 | industry: PE -4.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 5.18 - 5.98 ( +/- 7.10%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-15 | Llewelyn Linda | Sell | 2 005 | Common Stock |
| 2024-03-15 | Llewelyn Linda | Sell | 2 005 | Common Stock |
| 2024-03-01 | Lesueur Daniel | Buy | 70 000 | Common Stock |
| 2024-03-01 | Lesueur Daniel | Sell | 3 279 | Common Stock |
| 2024-03-01 | Alger Jason | Buy | 70 000 | Common Stock |
| INSIDER POWER |
|---|
| 68.98 |
| Last 99 transactions |
| Buy: 1 007 575 | Sell: 220 897 |
Forecast:
16:00 - $5.58
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $5.58
Forecast 2: 16:00 - $5.58
Forecast 3: 16:00 - $5.58
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $5.58 (-2.02% ) |
| Volume | 0.544 mill |
| Avg. Vol. | 0.613 mill |
| % of Avg. Vol | 88.74 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For HCAT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:34 | sell | $9.70 | N/A | Active |
|---|
HCAT
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
Last 10 Buy Signals
Latest Press Releases
2024-02-27 17:30:00 - Press Release
Health Catalyst Names Unitypoint Health Winner Of The 2024 Flywheel Award
Salt lake city , feb. 27, 2024 /prnewswire/ -- today, health catalyst announced the winner of the 2024 flywheel award. the award recognizes healthcare organizations that have showcased outstanding results in measurable, impactful improvements.
2024-02-22 16:03:00 - Press Release
Health Catalyst Reports Fourth Quarter And Year End 2023 Results
South jordan, utah., feb. 22, 2024 (globe newswire) -- health catalyst, inc. ("health catalyst," nasdaq: hcat), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended december 31, 2023.
2024-02-21 08:10:00 - Press Release
Health Catalyst's Able Health Registry Receives Cms's Qpp Qualified Registry Approval For 2024
Salt lake city , feb. 21, 2024 /prnewswire/ -- health catalyst, inc. ("health catalyst," nasdaq: hcat), a leading provider of data and analytics technology and services to healthcare organizations, today announced that the able health registry has received quality payment program (qpp) qualified registry approval for the 2024 performance year by the centers for medicare and medicaid services (cms). according to cms, the qpp program "aims to improve the quality and safety of care for all individuals and to reduce the administrative burden on clinicians, allowing more time to focus on person-centered care and improving health outcomes.
2024-02-21 08:00:00 - Press Release
Health Catalyst's Measureable™ Earns Onc Health It Certification
Salt lake city , feb. 21, 2024 /prnewswire/ -- health catalyst, inc. ("health catalyst," nasdaq: hcat), a leading provider of data and analytics technology and services to healthcare organizations, today announced measureable™ has achieved office of the national coordinator for health information technology (onc-health it) 2015 edition health it certification via drummond group llc, an authorized certification body (acb). this approval designates that eligible providers and hospitals may use measureable to meet requirements for various quality reporting programs that involve the use of certified electronic health records (ehr) technology to calculate and report quality measures.
2024-02-08 08:00:00 - Press Release
Health Catalyst To Announce Fourth Quarter And Full Year 2023 Operating Results And Host Conference Call On Thursday, February 22, 2024
Salt lake city, feb. 08, 2024 (globe newswire) -- health catalyst, inc. ("health catalyst", nasdaq: hcat), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2023 operating results on thursday, february 22, 2024, after market close. in conjunction, the company will host a conference call to review the results at 5 p.m. e.t. on the same day.
Latest News
2024-04-08 10:35:23 - Zacks Investment Research
Down -24.71% in 4 Weeks, Here's Why You Should You Buy the Dip in Health Catalyst (HCAT)
Health Catalyst (HCAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
2024-03-25 10:56:05 - Zacks Investment Research
Wall Street Analysts Think Health Catalyst (HCAT) Could Surge 53.65%: Read This Before Placing a Bet
The mean of analysts' price targets for Health Catalyst (HCAT) points to a 53.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
2024-03-20 15:01:12 - Zacks Investment Research
3 Medical Info Systems Stocks to Buy as Industry Improves
A few Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Talkspace (TALK) and Health Catalyst (HCAT) are expected to gain from the new normal trends.
2024-03-09 04:50:41 - Seeking Alpha
Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible
Health Catalyst reported strong Q4 results, meeting guidance and showing growth in technology and professional services revenue. The drop in HCAT's share price presents a buying opportunity, as the company's growth initiatives, such as its TEMS offering and next-gen data platform, are expected to drive growth and margin expansion. HCAT's long-term guidance of exceeding $100 million in EBITDA by FY28 is achievable, and its valuation should improve as it demonstrates execution and margin expansion.
2024-02-26 10:35:19 - Zacks Investment Research
After Plunging -24.47% in 4 Weeks, Here's Why the Trend Might Reverse for Health Catalyst (HCAT)
The heavy selling pressure might have exhausted for Health Catalyst (HCAT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
2024-02-22 23:49:09 - Seeking Alpha
Health Catalyst, Inc. (HCAT) Q4 2023 Earnings Call Transcript
2024-02-22 19:01:35 - Zacks Investment Research
Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
2024-02-22 18:26:09 - Zacks Investment Research
Health Catalyst (HCAT) Q4 Earnings and Revenues Beat Estimates
Health Catalyst (HCAT) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.05 per share a year ago.
2024-02-19 10:21:02 - Zacks Investment Research
Health Catalyst (HCAT) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Beyond analysts' top -and-bottom-line estimates for Health Catalyst (HCAT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
2024-02-08 08:00:00 - GlobeNewsWire
Health Catalyst to Announce Fourth Quarter and Full Year 2023 Operating Results and Host Conference Call on Thursday, February 22, 2024
SALT LAKE CITY, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2023 operating results on Thursday, February 22, 2024, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.